Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7610-7618
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Inflammatory response index | Pre-treatment | t | P value | Post-treatment | t | P value | ||
Observation group (n = 65) | Control group (n = 65) | Observation group (n = 65) | Control group (n = 65) | |||||
IL-6 (ng/L) | 25.78 ± 5.18 | 25.32 ± 4.63 | 2.132 | 0.097 | 20.36 ± 4.54b | 21.9 ± 5.47 | 1.891 | 0.012 |
IL-4 (ng/L) | 24.6 ± 4.34 | 23.4 ± 3.65 | 1.267 | 0.258 | 20.8 ± 5.56b | 22.8 ± 5.06 | 1.673 | 0.018 |
TNF-α (μg/L) | 1.27 ± 0.32 | 1.28 ± 0.63 | 1.879 | 0.784 | 0.43 ± 0.25b | 0.89 ± 0.48 | 2.693 | 0.014 |
- Citation: Cao JY, Wang YC, Deng XX. Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma. World J Clin Cases 2023; 11(31): 7610-7618
- URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7610.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7610